FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,151,886 | -5.9% | 4,729,419 | -1.8% | 0.57% | -6.2% |
Q4 2022 | $2,287,331 | -32.1% | 4,814,419 | 0.0% | 0.61% | -32.8% |
Q3 2022 | $3,370,000 | -20.3% | 4,814,419 | -1.0% | 0.91% | -43.9% |
Q2 2022 | $4,230,000 | -22.3% | 4,862,319 | 0.0% | 1.62% | -30.2% |
Q1 2022 | $5,446,000 | +46.6% | 4,862,319 | +159.1% | 2.32% | +87.8% |
Q4 2021 | $3,715,000 | -23.7% | 1,876,389 | +31.4% | 1.23% | -13.2% |
Q3 2021 | $4,867,000 | -56.7% | 1,427,481 | +3.5% | 1.42% | -45.7% |
Q2 2021 | $11,246,000 | -34.0% | 1,379,843 | -0.4% | 2.62% | -23.3% |
Q1 2021 | $17,033,000 | -31.5% | 1,384,743 | +1.7% | 3.41% | -51.3% |
Q4 2020 | $24,853,000 | +20.2% | 1,361,064 | +2.8% | 7.00% | -4.8% |
Q3 2020 | $20,673,000 | – | 1,324,364 | – | 7.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 2,950,000 | $5,841,000 | 5.58% |
CHI Advisors LLC | 1,876,389 | $3,715,000 | 1.23% |
TFG Asset Management GP Ltd | 1,522,859 | $3,015,000 | 0.18% |
Novo Holdings A/S | 1,776,613 | $3,518,000 | 0.17% |
HARBOR CAPITAL ADVISORS, INC. | 182,521 | $360,000 | 0.13% |
Eventide Asset Management | 3,485,656 | $6,746,000 | 0.09% |
Values First Advisors, Inc. | 23,048 | $46,000 | 0.03% |
Veritable, L.P. | 55,870 | $111,000 | 0.00% |
SG Americas Securities, LLC | 54,575 | $108,000 | 0.00% |
Renaissance Technologies | 210,100 | $416,000 | 0.00% |